Annals of Coloproctology

Display

Sort by :

Case Report

Ileocolonic Transposition Esophagogastric Bypass as an Antireflux Treatment for Corrosive Esophageal Injury: Yuda Handaya, Mukhamad Sunardi; Ann Coloproctol. 2017;33(4):150-155. Published online August 31, 2017; DOI: https://doi.org/10.3393/ac.2017.33.4.150

7,218 View
103 Download
1 Citations

Because most surgeons perform an esophagectomy and colonic transposition as the main reconstruction method for patients with esophageal stenosis caused by swallowing corrosive materials, we report 2 cases in which ileocolonic transposition was used to treat such patients. Both patients displayed stenosis in the middle third of the esophagus. Their chief complaint was dysphagia. Ileocolonic transposition using vascularization of the Drummond and ileal arteries was followed by a prepared ileocolic graft by ligating ileocolic vessels. We performed an ileocolonic transposition esophagogastric bypass without an esophagectomy. All surgeries resulted in minimal intraoperative bleeding. Patients experienced no leakage, postoperative fistulas, dysphagia, or postoperative reflux. Three weeks after surgery, 1 patient experienced reversible hoarseness caused by extensive laryngeal-nerve manipulation. Cumulatively, ileocolonic transposition with cervical anastomosis for the treatment of patients with esophageal stenosis caused by corrosive esophageal injury can be considered to be an antireflux treatment because the ileocaecal sphincter is maintained.

Citations

Citations to this article as recorded by

HYPERBARIC OXYGEN THERAPY AS AN ADJUVANT TREATMENT IN HYDROCHLORIC ACID POISONING: A LITERATURE REVIEW
Desi Rahmah Sari, Ismi Dian Meiliana, Dewangga Satria Sakti Kinasih, Hamidah Kurniasari, Purwo Sri Rejeki
Majalah Biomorfologi.2023; 33(1): 52. CrossRef

Original Article

Multivariate Analysis of the Survival Rate for Treatment Modalities in Incurable Stage IV Colorectal Cancer: Sung Kang Kim, Chang Ho Lee, Min Ro Lee, Jong Hun Kim; J Korean Soc Coloproctol. 2012;28(1):35-41. Published online February 29, 2012; DOI: https://doi.org/10.3393/jksc.2012.28.1.35

5,853 View
38 Download
14 Citations

Abstract PDF

Purpose

The aim of this study was to compare survival in patients that underwent palliative resection treatment versus non-resection for incurable colorectal cancer (ICRC).

Methods

The case records of 201 patients with ICRC between January 2000 and December 2009 were reviewed. Demographics, American Society of Anesthesiologists (ASA) score, carcinoembryonic antigen (CEA) level, the location of the colon cancer, histology, metastasis, treatment options and median survival were analyzed retrospectively. We divided the patients into four groups according to the treatment modalities: resection alone, resection with post-operative chemotherapy, non-resection treatment by chemotherapy alone, and stent or bypass. Median survival times were compared according to each treatment option, and the survival rates were analyzed.

Results

105 patients underwent palliative resection whereas 96 were treated with non-resection modalities. A palliative resection was performed in 44 cases for resection alone and in 61 cases for resection with post-operative chemotherapy. In patients treated with non-resection of the primary tumor, chemotherapy alone was done in 65 cases and stent or bypass in 31 cases. Multivariate analysis showed a median survival of 14 months in patients with palliative resections with post-operative chemotherapy, which was significantly higher than those for chemotherapy alone (8 months), primary tumor resection alone (5 months), and stent or bypass (5 months). Gender, age, ASA score, CEA level, the location of colon cancer, histology and the presence of multiple metastases were not independent factors in association with the median survival rate.

Conclusion

In the treatment of ICRC, palliative resection followed by post-operative chemotherapy shows the most favorable median survival compared to other treatment options.

Citations

Citations to this article as recorded by

Incidence and determinants of mortality among patients with colorectal cancer in oncology centers of Amhara region, Ethiopia, 2024: multicenter retrospective follow up study
Getachew Tesfaw Walle, Tegene Atamenta Kitaw, Seteamlak Adane
BMC Cancer.2025;[Epub] CrossRef
Biopsy sampling during self-expandable metallic stent placement in acute malignant colorectal obstruction: a narrative review
Sigrid Skov Bennedsgaard, Lene Hjerrild Iversen
World Journal of Surgical Oncology.2021;[Epub] CrossRef
National statistics about resection of the primary tumor in asymptomatic patients with Stage IV colorectal cancer and unresectable metastases. Need for improvement in data collection. A systematic review with meta-analysis
Antonio V. Sterpetti, Umberto Costi, Giuseppe D'Ermo
Surgical Oncology.2020; 33: 11. CrossRef
Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta‐analysis
Constantinos Simillis, Eliana Kalakouti, Thalia Afxentiou, Christos Kontovounisios, Jason J. Smith, David Cunningham, Michel Adamina, Paris P. Tekkis
World Journal of Surgery.2019; 43(7): 1829. CrossRef
Long-Chain Noncoding RNAPVT1Gene Polymorphisms Are Associated with the Risk and Prognosis of Colorectal Cancer in the Han Chinese Population
Lei Zhang, Jiehong Mao
Genetic Testing and Molecular Biomarkers.2019; 23(10): 728. CrossRef
Meta-analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer
U Nitsche, C Stöß, L Stecher, D Wilhelm, H Friess, G O Ceyhan
Journal of British Surgery.2018; 105(7): 784. CrossRef
A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumour
Deena P. Harji, Abigail Vallance, Jenny Selgimann, Simon Bach, Faheez Mohamed, Julia Brown, Nicola Fearnhead
European Journal of Surgical Oncology.2018; 44(10): 1469. CrossRef
Meta-analysis of oncologic effect of primary tumor resection in patients with unresectable stage IV colorectal cancer in the era of modern systemic chemotherapy
Gi Won Ha, Jong Hun Kim, Min Ro Lee
Annals of Surgical Treatment and Research.2018; 95(2): 64. CrossRef
Prognostic Implications of Primary Tumor Resection in Stage IVB Colorectal Cancer in Elderly Patients
Heui-June Ahn, Ho-Suk Oh, Yongchel Ahn, Sang Jin Lee, Hyun Joong Kim, Moon Ho Kim, Dae-Woon Eom, Jae Young Kwak, Myoung Sik Han, Jae Seok Song
Annals of Coloproctology.2014; 30(4): 175. CrossRef
A Meta-Analysis to Determine the Effect of Primary Tumor Resection for Stage IV Colorectal Cancer with Unresectable Metastases on Patient Survival
Cillian Clancy, John P. Burke, Mitchel Barry, Matthew F. Kalady, J. Calvin Coffey
Annals of Surgical Oncology.2014; 21(12): 3900. CrossRef
Palliative laparoscopic bowel resection in stage IV colorectal cancer patients with unresectable metastasis
Kwan Mo Yang, Seok-Byung Lim, Yong Sik Yoon, Chan Wook Kim, In Ja Park, Chang Sik Yu, Jin Cheon Kim
Korean Journal of Clinical Oncology.2013; 9(2): 134. CrossRef
Recent Advances in the Management of Stage IV Colon Cancer
Rani Kanthan, Jenna-Lynn Senger, Shahid Ahmed, Selliah Kanthan
Journal of Cancer Therapy.2012; 03(06): 1104. CrossRef
Kolonstents als «Bridge to Surgery»
Karl E. Grund, Annette Zipfel
Visceral Medicine.2012; 28(6): 412. CrossRef
Review and Evaluation of Methods Correcting for Population Stratification with a Focus on Underlying Statistical Principles
Hemant K. Tiwari, Jill Barnholtz-Sloan, Nathan Wineinger, Miguel A. Padilla, Laura K. Vaughan, David B. Allison
Human Heredity.2008; 66(2): 67. CrossRef

First
Prev
Page of 1
Next
Last

Search